NCT06396780

Brief Summary

The aim of this study is to describe the current status of treatment adherence in children with Helicobacter pylori infection, understand the medication literacy, medication beliefs of the children, knowledge of H. pylori among caregivers, medication beliefs, medication support, and explore the influencing factors of medication adherence.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
233

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 30, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 2, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

April 30, 2024

Last Update Submit

July 18, 2024

Conditions

Keywords

H.pylori infectionMedication AdherenceMedication BeliefsMedication KnowledgeMedication SupportHelicobacter pylori knowledge

Outcome Measures

Primary Outcomes (1)

  • Status of adherence

    Using the Medication Adherence Questionnaire to assess the level of medication adherence in pediatric patients. The questionnaire primarily includes four aspects: adherence to timing, dosage, frequency, and persistence in taking medication. Each aspect consists of four options: (1) Impossible to do; (2) Occasionally possible to do; (3) Basically possible to do; (4) Completely possible to do. Using a scoring method, each option is assigned a score of 1, 2, 3, or 4, respectively, with a score range of 4 to 16 points. Complete adherence is scored as 16 points, basic adherence as 13 to 15 points, minimal adherence as 5 to 12 points, and difficulty as 4 points.

    baseline

Secondary Outcomes (4)

  • Medication literacy

    Baseline

  • Beliefs about medicine

    Baseline

  • Medication support

    Baseline

  • Helicobacter pylori knowledge

    Baseline

Study Arms (1)

Participants who meet the inclusion/exclusion criteria will be invited to complete the questionnaire

Children will be invited to complete the Medication Adherence Questionnaire, Medication Literacy Questionnaire, and Medication Beliefs Specific Questionnaire. Caregivers will be invited to complete the Helicobacter pylori Knowledge Questionnaire, Medication Beliefs Specific Questionnaire, and Medication Support Questionnaire.

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Eradication of helicobacter pylori in children

You may qualify if:

  • Children aged 8-18 years old
  • \. whose diagnosis meets the diagnostic criteria for Helicobacter pylori infection in the Expert Consensus on Diagnosis and Treatment of Helicobacter Pylori Infection in Chinese Children (2022)
  • \. Children who receive Helicobacter pylori eradication therapy

You may not qualify if:

  • Children are diagnosed with other chronic conditions and take other medications for a long time
  • Unable to communicate with readers in Chinese normally
  • Caregivers of children who meet the diagnostic criteria for Helicobacter pylori infection in the Expert Consensus on Diagnosis and Treatment of Helicobacter pylori Infection in Children in China (2022)
  • Able to communicate normally
  • Not living with children
  • Not familiar with the use of children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

Location

MeSH Terms

Conditions

Medication Adherence

Condition Hierarchy (Ancestors)

Patient CompliancePatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Wei Xia, PhD

    Sun Yat-sen University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Association Professor

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 2, 2024

Study Start

March 30, 2024

Primary Completion

February 28, 2025

Study Completion

March 31, 2025

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

The non-identified individual participant data will be shared after the outcomes have been published.

Shared Documents
SAP
Time Frame
After the publication of the study
Access Criteria
Researchers should contact the PI for approval of the study protocol

Locations